Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-19-006252)

Filing Details

Accession Number:: 0001562180-19-006252
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-23 16:41:47
Reporting Period:: 2019-12-23

Accepted Time:: 2019-12-23 16:41:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1690585	Magenta Therapeutics Inc.	MGTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741286	Jason Gardner	C/O Magenta Therapeutics, Inc. 100 Technology Square Cambridge MA 02139	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-23	2,897	$15.10	265,212	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	292,990	Indirect	By J.P. Gardner Irrevocable Trust
Common Stock	359,092	Indirect	By P.S. Gardner Irrevocable Trust

Footnotes

This trade is pursuant to an active 10b5-1 plan.
This transaction was executed in multiple trades at prices ranging from $15.10 to $15.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.